Our Impact
We are invested in making a meaningful difference in the lives of patients and their families around the globe.
We do this by advancing innovative solutions for clinical practice that are sustainable, cost-effective and accessible.
2025 Annual Report
Read the annual report to learn how Fogarty Innovation accelerated the invention, development, and deployment of new technologies into clinical care in 2025. The report covers accomplishments in our educational programming, the progress of companies and entrepreneurs in our incubation programs, and an update on our alliance partners and how we work together to streamline the path to patient care.
2025 Highlights
We are proud to share some of our 2025 accomplishments
Incubation
- Hosted 32 companies across our incubation and acceleration portfolio in 2025
- Overall, our companies in development have raised $347M during their time at FI and gone on to raise more than $1.5B after graduation. (2024)
- 79% of graduates successfully raise capital after completing our programs. (2024)
- Our success rate in terms of companies experiencing a positive liquidity event is 5x the industry average.
Education
- Organized 25 in-person half-day workshops and Lunch & Learns for our entrepreneurs and the innovation community.
- These educational programs earned a net promoter score [1] of 85 – higher than Amazon, Google and Apple.
- Developed the fourth TCT Medtech Innovation Forum, a full day event on the first day of TCT, in partnership with the Cardiovascular Research Foundation.
- Hosted our twelfth class of the Lefteroff summer interns, 157 interns to date.
- Diversity by Doing HealthTech organized the third Pathways in Health Technology program, which introduces community college students to careers in medtech.
[1] Net Promoter Score® is a measure used to gauge customer loyalty, satisfaction, and enthusiasm, calculated by asking customers this question: “On a scale from 0 to 10, how likely are you to recommend this product/company to a friend or colleague?” A rating of -100 to 0 needs improvement, 0 to 30 is good, 30 to 70 is great and 70 to 100 is excellent.
Alliances
- Expanded our long-term collaboration with A*STAR, Singapore by signing a formal partnership with MedTech Catapult, a national initiative designed to fund and accelerate later-stage health technology companies.
- Partnered with Dartmouth Health and the Geisel School of Medicine to support the 3D Scholars program, a certificate program to train physicians in the business of medical device innovation.
- Collaborated with leaders from American Urological Association to develop the 2025 Innovation Nexus Conference, a one-day symposium focused on entrepreneurship.
- Supported the UCSF-Stanford Pediatric Device Consortium, providing four Fogarty Physicals to early-stage pediatric companies and selecting one company, AVaTAR Medtech, to join our Company Accelerator Program.

The Thomas J. Fogarty Innovation Prize
In partnership with founding sponsor, the Mussallem Foundation, we launched the inaugural Thomas J. Fogarty Innovation Prize. The award is named in honor of Tom Fogarty, MD, and recognizes an innovator or team who has developed and broadly commercialized a life-changing medical technology.
Helping Companies Advance
Making Medical Innovation Happen
CEOs from current and alumni Fogarty Innovation companies describe the unique benefits of incubating their companies at Fogarty Innovation – including tailored, practical educational programming; “full contact” coaching from highly experienced and committed staff; leadership training; and the lifelong support of a dedicated community of health technology innovators and entrepreneurs.
Training Entrepreneurs
—Cam Hutton, Founder, Healyx Labs
Training Global Health Entrepreneurs
Healyx Labs was founded out of Stanford’s Design for Extreme Affordability class with the goal of advancing wound care in low resource, low income settings. The company’s first product was designed to provide the gold standard treatment, negative wound pressure therapy, using a simple, low-cost technology that met the resources and environment where it would be utilized.
Learn more about Healyx Labs and how Fogary Innovation supported Cam’s evolution from student to medtech innovator and leader.
Creating Opportunity
—Jaclyn Babcock, Former Director, Career Pathways Programs
Boys & Girls Clubs of the Peninsula
Boys & Girls Clubs of the Peninsula
Boys & Girls Clubs of the Peninsula serves the communities of Redwood City, Menlo Park, and East Palo Alto. The organization works to empower students with access to social, academic, and career opportunities to thrive. Fogarty Innovation partners with BGCP to introduce students to medical technology innovation as a career path and provide them with opportunities to observe clinical medicine and gain hands-on experience in health technology innovation and development.
FI Gives Back

FI Gives Back is an initiative spearheaded by Julie Rose, Allie Gregorian, and Lizbeth Villalobos that gives our employees and resident companies a way to give back to our local community. Launched in 2024, this program has become a cornerstone of our commitment to creating positive change.
We organize opportunities throughout the year that range from volunteering time to supporting causes through donations. Through these initiatives, we help raise awareness and contribute to important needs like educational preparedness, hunger, and holiday inclusion.
Our giving partners to date include Family Giving Tree, Second Harvest Food Bank, and the Santa Clara County Fire Department.
Impact/Success Stories
Flosonics – From Company Accelerator Program to Commercial
Medtech success stories are always inspiring and there is nothing better than hearing one from a Fogarty alumni company. Joe Eibl, CEO of Flosonics, visited FI earlier this month to give a Lunch & Learn educational talk describing his company’s journey from...
EchoPixel’s 4D Hologram Technology Used to Successfully Complete First Structural Heart Procedure
Fogarty graduate EchoPixel helped revolutionize heart surgery with its True3D, a turnkey surgical planning software that creates a hologram of the heart for study before an incision is ever made. With FDA 510(k) clearance, True3D has already been implemented by more...
PQ Bypass Acquired by Endologix for its Innovative Procedure
PQ Bypass, one of the first Fogarty Innovation startups, was recently acquired by Endologix LLC, a leader in the treatment of vascular disease. The addition of the PQ Bypass technology portfolio, which targets the treatment of complex superficial femoral artery (SFA)...


